Eugénio Teófilo

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults

Edwin DeJesus, Gisela Herrera, Eugénio Teófilo et al. · Clinical Infectious Diseases · 2004 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

Catherine Orrell, Debbie Hagins, Elena Belonosova et al. · The Lancet HIV · 2017 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in Portugal

Vítor Borges, Mariana Perez Duque, João Vieira Martins et al. · Nature Medicine · 2023 · 50 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients

Robin Wood, Keikawus Arastéh, Hans‐Jürgen Stellbrink et al. · Antimicrobial Agents and Chemotherapy · 2003 · 46 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16